Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055484 · ClinicalTrials.gov registry record · Phase 2
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
A Phase 2 study, sponsored by Elan Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 204
- Enrollment target
NCT00055484 is a Phase 2 study that has completed, run by Elan Pharmaceuticals. The registered enrollment target is 204 participants.
The verdict
NCT00055484, a Phase 2 study, has completed, sponsored by Elan Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 204 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
Interventions
- DRUG zonisamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2002-03 |
| Est. Completion | 2003-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00055484
The ClinicalTrials.gov registry entry for NCT00055484 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elan Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which zonisamide is the first listed.
NCT00055484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00055484 about?
NCT00055484 is a clinical study titled "A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache". The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
What is the current status of trial NCT00055484?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 204 participants. The study started on 2002-03. Estimated completion is 2003-05.
What interventions are being tested in trial NCT00055484?
The interventions under investigation include: zonisamide (DRUG).
Who is sponsoring clinical trial NCT00055484?
This trial is sponsored by Elan Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.